One-year results of the SGX SCS RCT trial show spinal cord stimulation with Medtronic’s proprietary differential target multiplexed (DTM) waveform is more effective than conventional spinal cord stimulation for treating of chronic back pain.
The DTM waveform is a proprietary multiplexed algorithm that coordinates multiple signals and anatomical targets in the patient's spine to customize the therapy to each patient, Charlie Covert, general manager of Medtronic’s pain therapies business, told Medtech Insight